Tianjin Tianyao Pharmaceuticals Co., Ltd. Tianjin Tianyao Pharmaceuticals Co., Ltd.

Tianjin Tianyao Pharmaceuticals Co., Ltd.

600488

Rank in Stocks #9901
Tianjin Tianyao Pharmaceuticals Co., Ltd. is a Chinese enterprise primarily... Tianjin Tianyao Pharmaceuticals Co., Ltd. is a Chinese enterprise primarily engaged in the research, manufacturing, and export of active pharmaceutical ingredients (APIs) across the Asian market. The company's core product offerings include APIs and formulated drugs for corticosteroid, cardio cerebrovascular, and analgesic applications. Its extensive portfolio of bulk drug substances encompasses numerous compounds such as dexamethasone and its various salts and esters, prednisone, prednisolone, flucinonide, halcinonide, triamcinolone and its derivatives, clobetasol propionate, betamethasone, and methylprednisolone. Based in Tianjin, China, Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHSE: 600488) operates as a subsidiary of Jinhushen Biomedical Technology Co., Ltd.
Share Price
$0.70757722
Last synced: 2026-11-13
Market Cap
$772.59M
Change (1 day)
-4.26%
Change (1 year)
12.26%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488)

Category

Healthcare
EPS for Tianjin Tianyao Pharmaceuticals Co., Ltd. (600488)
EPS as of September 2026 TTM: $0.01
According to Tianjin Tianyao Pharmaceuticals Co., Ltd.'s latest financial reports, its current EPS (TTM) is $0.01. At the end of 2025 the company had an EPS of $0.01, a decrease compared to its 2024 EPS of $0.02.
EPS history for Tianjin Tianyao Pharmaceuticals Co., Ltd. from 2000 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $0.01 -36.00%
2025 $0.01 -43.29%
2024 $0.02 5.81%
2023 $0.02 236.96%
2022 0.00 -35.21%
2021 $0.01 51.06%
2020 0.00 -78.14%
2019 $0.02 13.76%
2018 $0.02 2.72%
2017 $0.02 41.54%
2016 $0.01 3.17%
2015 $0.01 -13.10%
2014 $0.01 46.46%
2013 $0.01 -52.40%
2012 $0.02 19.54%
2011 $0.02 4.19%
2010 $0.02 42.74%
2009 $0.01 28.57%
2008 $0.01 89.58%
2007 0.00 -43.53%
2006 $0.01 -42.95%
2005 $0.01 12.03%
2004 $0.01 14.66%
2003 $0.01 -0.85%
2002 $0.01 20.62%
2001 $0.01 -19.83%
2000 $0.01 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$6.03 94,117.19%
DE
$6.01 93,771.88%
DE
$1.53 23,851.56%
JP
$3.66 57,087.50%
CH
$0.45 6,931.25%
IL

Questions about Tianjin Tianyao Pharmaceuticals Co., Ltd.'s earnings per share (EPS)

What is Tianjin Tianyao Pharmaceuticals Co., Ltd.'s earnings per share (EPS)?

Tianjin Tianyao Pharmaceuticals Co., Ltd.'s earnings per share (EPS) over the last twelve months is $0.01, as of Sep 2026.

What was Tianjin Tianyao Pharmaceuticals Co., Ltd.'s earnings per share (EPS) in 2025?

In 2025, Tianjin Tianyao Pharmaceuticals Co., Ltd.'s earnings per share (EPS) was $0.01, 50.00% less than in 2024 ($0.02).

How has Tianjin Tianyao Pharmaceuticals Co., Ltd.'s earnings per share (EPS) changed since 2020?

From 2020 to 2025, Tianjin Tianyao Pharmaceuticals Co., Ltd.'s earnings per share (EPS) was highest in 2024 ($0.02) and lowest in 2022 (0.00).

How does Tianjin Tianyao Pharmaceuticals Co., Ltd.'s earnings per share (EPS) compare with similar companies?

Tianjin Tianyao Pharmaceuticals Co., Ltd.'s earnings per share (EPS) ($0.01) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.